Remote Jobs at PreludeDx

PreludeDx

11 - 50 employees

🧬 Biotechnology

🏥 Healthcare

💊 Pharmaceuticals

💰 $20M Venture Round on 2022-03

Biotechnology • Healthcare • Pharmaceuticals

PreludeDx is a biotechnology company focused on providing actionable tools for managing early stage breast cancer. Its primary diagnostic test, DCISionRT, was developed after more than a decade of research aimed at addressing the critical question for patients with Ductal Carcinoma In Situ (DCIS) regarding their risk of recurrence and appropriate treatment options. PreludeDx began its developmental journey in 2009, having licensed innovative technology from the University of California, San Francisco.